Tamidental, UAB - financials and debts

Company age: 13 y. 6 mo.

Update

Tamidental - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 160,140 159,326 127,822 201,726 169,622 145,125 123,954 129,534
Profit before tax 31,319 9,593 23,771 30,072 11,112 32,529 22,941 28,403
Net profit 29,753 9,095 22,536 28,536 10,449 30,775 21,781 26,551
Equity 73,953 83,048 105,583 133,953 34,613 49,889 46,671 38,221
Liabilities 37,549 17,228 22,799 21,443 70,560 60,696 67,388 61,110
Non-current assets 41,559 31,808 37,730 34,024 62,453 52,634 46,404 33,267
Current assets 69,943 68,280 90,477 121,006 42,720 57,582 67,655 65,670
Total assets 111,502 100,088 128,207 155,030 105,173 110,216 114,059 98,937
Taxes paid
STI taxes - - - - - 9,019 10,179 12,623
Social insurance contributions - - - - - 1,212 - -
Financial indicators
Revenue change y/y +46.9% -0.5% -19.8% +57.8% -15.9% -14.4% -14.6% +4.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 26.7% 9.1% 17.6% 18.4% 9.9% 27.9% 19.1% 26.8%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 40.2% 11.0% 21.3% 21.3% 30.2% 61.7% 46.7% 69.5%
Profit margin Net profit margin. Shows the overall profitability of the company. 18.6% 5.7% 17.6% 14.1% 6.2% 21.2% 17.6% 20.5%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 19.6% 6.0% 18.6% 14.9% 6.6% 22.4% 18.5% 21.9%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.5 0.2 0.2 0.2 2.0 1.2 1.4 1.6
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 39,218 32,405 25,998 37,241 33,368 39,579 41,318 61,951

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Tamidental - Social security debts

From To Debt, €
2022-11-21 2022-12-12 3.45
2022-11-17 2022-11-18 3.45
2022-10-18 2022-10-30 4.36

Tamidental - VMI tax arrears

From To Overdue, €
2026-08-17 2026-08-17 3.73
2026-08-12 2026-08-16 0.28
2026-08-02 2026-08-11 790.96
2026-07-16 2026-08-01 777.36
2026-06-26 2026-07-15 0.28
2026-04-01 2026-05-30 0.02
2025-12-18 2026-01-15 0.08
2025-10-02 2025-11-30 0.04
2025-03-20 2025-03-24 341.99

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Tamidental, UAB (code 303025442) is a Private Limited Liability Company engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated revenue of €129.5K and net profit of €26.6K, corresponding to a profit margin of 20.5%. Revenue increased by 4.5% year on year, after falling from €145.1K in 2023 to €124.0K in 2024, so the latest result shows a partial recovery, although revenue remained below the 2023 level. Net profit followed a similar pattern, decreasing from €30.8K in 2023 to €21.8K in 2024 and then improving in 2025. At the end of 2025, total assets stood at €98.9K, equity at €38.2K and liabilities at €61.1K, with an equity ratio of 38.6% and debt-to-equity of 1.60. Asset turnover was 1.31x. Revenue per employee was €64.8K and profit per employee €13.3K, indicating efficient use of staff resources.